BioCentury | Aug 22, 2019
Financial News

Microbiome company Finch raises $53M ahead of anti-infective readout

...Partners, Susquehanna International Group, Symbiosis and the Trans-Pacific Technology Fund, as well as existing investors Avenir Growth Capital...
BioCentury | Mar 2, 2018
Financial News

Finch Therapeutics raises $36 million series B round

...1 in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital...
BioCentury | Mar 1, 2018
Financial News

Finch Therapeutics raises $36M series B round

...million in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital...
Items per page:
1 - 3 of 3
BioCentury | Aug 22, 2019
Financial News

Microbiome company Finch raises $53M ahead of anti-infective readout

...Partners, Susquehanna International Group, Symbiosis and the Trans-Pacific Technology Fund, as well as existing investors Avenir Growth Capital...
BioCentury | Mar 2, 2018
Financial News

Finch Therapeutics raises $36 million series B round

...1 in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital...
BioCentury | Mar 1, 2018
Financial News

Finch Therapeutics raises $36M series B round

...million in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital...
Items per page:
1 - 3 of 3